Management of Chronic Heart Failure with Reduced Ejection Fraction.
J Am Board Fam Med
; 37(3): 364-371, 2024.
Article
en En
| MEDLINE
| ID: mdl-39142870
ABSTRACT
Heart failure with reduced ejection fraction (HFrEF) is a commonly seen clinical entity in the family physician's practice. This clinical review focuses on the pharmacologic management of chronic HFrEF. Special attention is paid to the classification of heart failure and the newest recommendations from the American Heart Association concerning the use of guideline-directed medical therapy. ß blockers, ACE inhibitors, ARBs, mineralocorticoid receptor antagonists are discussed in detail. The new emphasis on sacubitril-valsartan and SGLT2i's as therapies for HFrEF are reviewed, followed by a brief discussion of more advanced therapies and comorbidity management.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Volumen Sistólico
/
Antagonistas Adrenérgicos beta
/
Antagonistas de Receptores de Mineralocorticoides
/
Antagonistas de Receptores de Angiotensina
/
Insuficiencia Cardíaca
Límite:
Humans
Idioma:
En
Revista:
J Am Board Fam Med
Año:
2024
Tipo del documento:
Article
Pais de publicación:
Estados Unidos